Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4564
Peer-review started: August 31, 2014
First decision: September 27, 2014
Revised: November 4, 2014
Accepted: December 5, 2014
Article in press: December 8, 2014
Published online: April 21, 2015
Processing time: 234 Days and 1.4 Hours
AIM: To investigate the mechanism by which miR-19a is up-regulated in gastric cancer (GC), which plays an oncogenic role.
METHODS: In the present study, we investigated the role of miR-19a in gastric tissues as well as two GC cell lines. In vivo, we detected the basal expression level of miR-19a using real-time reverse transcription-PCR (RT-PCR), and the relevance between expression of miR-19a and clinicopathological information was analyzed. In vitro, miR-19a was ectopically expressed using overexpression and knock-down strategies.
RESULTS: Overexpression of miR-19a was significantly associated with metastasis of GC and inferior overall prognosis. However, no significant correlation was found between miR-19a expression and other characteristics such as age, gender, tobacco, alcohol or tumor size. Cell proliferation, migration and invasion assays showed that overexpression of miR-19a promoted the proliferation, migration and invasion, and that overexpression of miR-19a promoted the epithelial-mesenchymal transition through activating the PI3K/AKT pathway. Blocking the PI3K/AKT pathway could cancel the effect of miR-19a.
CONCLUSION: All together, our results suggest that miR-19a could be used as a promising therapeutic target in the treatment of GC.
Core tip: We found that miR-19a modulates epithelial-mesenchymal transition by activating the PI3K/AKT pathway. This miR-19a-PI3K/AKT axis sheds new light on the mechanisms of oncogenic roles of miR-19a in gastric cancer.